METASTATIC CARCINOMA IN THE LIVER
Clinical trials for METASTATIC CARCINOMA IN THE LIVER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CARCINOMA IN THE LIVER trials appear
Sign up with your email to follow new studies for METASTATIC CARCINOMA IN THE LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise in early trial for liver-metastatic colorectal cancer
Disease control CompletedThis early-phase study tested the safety of combining the immunotherapy drug pembrolizumab with precise, high-dose radiation (SBRT) to the liver in 15 adults with colorectal cancer that had spread only to the liver. The goal was to see if this combination could prevent the cancer…
Matched conditions: METASTATIC CARCINOMA IN THE LIVER
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New combo therapy aims to supercharge immune attack on tough cancers
Disease control CompletedThis study tested a combination of three immunotherapy drugs (ipilimumab, nivolumab, and BMS-986156) with or without precise radiation therapy in 51 people with advanced solid cancers that had spread to the liver or lungs. The goal was to find the safest dose of BMS-986156 and se…
Matched conditions: METASTATIC CARCINOMA IN THE LIVER
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC